Molina Healthcare (MOH)
(Delayed Data from NYSE)
$360.94 USD
+1.09 (0.30%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $360.84 -0.10 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum C VGM
Income Statements
Fiscal Year end for Molina Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 34,072 | 31,974 | 27,771 | 19,423 | 16,829 |
Cost Of Goods | 28,669 | 27,175 | 23,704 | 15,820 | 13,905 |
Gross Profit | 5,403 | 4,799 | 4,067 | 3,603 | 2,924 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,830 | 3,626 | 3,047 | 2,525 | 1,880 |
Income After Depreciation & Amortization | 1,573 | 1,173 | 1,020 | 1,078 | 1,044 |
Non-Operating Income | 0 | 0 | -25 | -15 | 15 |
Interest Expense | 109 | 110 | 120 | 102 | 87 |
Pretax Income | 1,464 | 1,063 | 875 | 961 | 972 |
Income Taxes | 373 | 271 | 216 | 288 | 235 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,091 | 792 | 659 | 673 | 737 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1,091 | 792 | 659 | 673 | 737 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,744 | 1,349 | 1,151 | 1,166 | 1,138 |
Depreciation & Amortization (Cash Flow) | 171 | 176 | 131 | 88 | 94 |
Income After Depreciation & Amortization | 1,573 | 1,173 | 1,020 | 1,078 | 1,044 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 58.10 | 58.50 | 58.60 | 59.90 | 64.20 |
Diluted EPS Before Non-Recurring Items | 20.88 | 17.92 | 13.54 | 10.67 | 11.57 |
Diluted Net EPS (GAAP) | 18.77 | 13.55 | 11.25 | 11.23 | 11.47 |
Fiscal Year end for Molina Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 9,048.00 | 8,548.00 | 8,327.00 | 8,149.00 |
Cost Of Goods | NA | 7,454.00 | 7,306.00 | 7,038.00 | 6,871.00 |
Gross Profit | NA | 1,594.00 | 1,242.00 | 1,289.00 | 1,278.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,278.00 | 883.00 | 846.00 | 823.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 316.00 | 359.00 | 443.00 | 455.00 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 27.00 | 27.00 | 27.00 | 28.00 |
Pretax Income | NA | 289.00 | 332.00 | 416.00 | 427.00 |
Income Taxes | NA | 73.00 | 87.00 | 107.00 | 106.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 216.00 | 245.00 | 309.00 | 321.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 216.00 | 245.00 | 309.00 | 321.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 58.20 | 58.10 | 57.90 | 58.00 |
Diluted EPS Before Non-Recurring Items | NA | 4.38 | 5.05 | 5.65 | 5.81 |
Diluted Net EPS (GAAP) | NA | 3.69 | 4.21 | 5.35 | 5.52 |